Editor-in-Chief’s Commentary: SAGE Publishes the Drug Information Journal J. Rick Turner Commentary 31 December 2012 Pages: 5 - 6
The Ditchley Transparency Manifesto Ragnar LofstedtFrederic Bouder Commentary 31 December 2012 Pages: 7 - 7
An In-Process Scaling Model: A Potential Framework for Data Monitoring Committees and Clinical Trial Quality Improvement Alan SmithJonathan Seltzer Clinical Trials 31 December 2012 Pages: 8 - 12
Flexible Phase I Study Designs: Expediting Early Clinical Drug Development David Underwood Clinical Trials 31 December 2012 Pages: 13 - 18
Exposure to and Understanding of Technical Terms in Informed Consent Forms for Biomedical Research Ihn Sook JeongDong-Hee KimJi Hong Shon Clinical Trials 31 December 2012 Pages: 19 - 26
Patient Nonadherence in Clinical Trials: Could There Be a Link to Postmarketing Patient Safety? Dorothy L. Smith Clinical Trials 31 December 2012 Pages: 27 - 34
Improving Time to Pharmaceutical Approval: An Analysis of the Prescription Drug User Fee Act Process Andrea C. MascialePatricia L. DeSantisJay P. Siegel Clinical Trials 31 December 2012 Pages: 35 - 42
Experiences With the Approval of Clinical Trials in Germany: Results of a Survey of Research-Based Pharmaceutical Companies Thorsten RuppertBoris Mirko Pfeiffer Clinical Trials 31 December 2012 Pages: 43 - 56
An Appraisal of Good Regulatory Review Practices in the Gulf Cooperation Council States Reem Al-EssaSam SalekStuart Walker Regulatory Affairs 31 December 2012 Pages: 57 - 64
Regulatory Review Process in the Gulf Cooperation Council States: Similarities and Differences Reem Al-EssaSam SalekStuart Walker Regulatory Affairs 31 December 2012 Pages: 65 - 72
Development and Application of Scorecards to Assess the Quality of a Regulatory Submission and Its Review Sam SalekAndrea Mallia-MilanesStuart Walker Regulatory Affairs 31 December 2012 Pages: 73 - 83
CPI™ Certification as Predictor of Clinical Investigators’ Regulatory Compliance David M. Vulcano Regulatory Affairs 31 December 2012 Pages: 84 - 87
Providing Medical Information for Orphan Drugs Sean TurbevilleDavid A. WellsCarl S. Hornfeldt Drug Information 31 December 2012 Pages: 88 - 93
The Correction of Product Information in Drug References and Medical Textbooks Ching Lum PharmDSoo Mi Ahn PharmD Drug Information 31 December 2012 Pages: 94 - 98
The Association Between Leukotriene-Modifying Agents and Spontaneously Reported Suicide Glen T. SchumockRobert D. GibbonsRobert J. Valuck Drug Information 31 December 2012 Pages: 99 - 106
The Role of Pharmaceutical Medical Information in Promotional Review: Three Benchmarking Surveys Lisa BonkMadhuri KothariEllen Yang Drug Information 31 December 2012 Pages: 107 - 114
Text Analytics for Surveillance (TAS): An Interactive Environment for Safety Literature Review Camilla ChristenssonGeoffrey GipsonJames Weatherall Drug Information 31 December 2012 Pages: 115 - 123
The Electronic Common Technical Document (eCTD): An International Pro/Con Analysis of the Pharmaceutical Product Electronic Submission Process Andreas SuchanekHerwig Ostermann Student Papers 31 December 2012 Pages: 124 - 139
Cobert’s Manual of Drug Safety and Pharmacovigilance Edward Tabor Book Reviews 31 December 2012 Pages: 140 - 140